3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Urinary Bladder Neoplasms
2
Triple Negative Breast Neoplasms
1
Small Cell Lung Carcinoma
1
Recurrence
1
Prostatic Neoplasms
1
Osteosarcoma
1
Non-Muscle Invasive Bladder Neoplasms
1
Neoplasms
1
Lymphoma, T-Cell, Peripheral
1
Immunoblastic Lymphadenopathy
1
Carcinoma in Situ
1
Breast Neoplasms
1
Advanced Solid Tumor Cancer
1
Interventions
Bevacizumab
5
Cetuximab
3
palbociclib
2
encorafenib
2
Leucovorin
2
Irinotecan
2
Fluorouracil
2
tislelizumab
1
ribociclib
1
repotrectinib
1
olaparib
1
fludarabine
1
durvalumab
1
dostarlimab
1
atezolizumab
1
Tretinoin
1
Stem Cell Transplantation
1
Sirolimus
1
Ramucirumab
1
Radiotherapy
1
Paclitaxel
1
Oxaliplatin
1
Oviposition
1
Melphalan
1
Lutetium-177
1
Lutetium
1
Levoleucovorin
1
Injections
1
Immunotherapy
1
Imatinib Mesylate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Digestive System Neoplasms
×
Clinical Trials, Phase II as Topic
×
1 year
×
Clear all
No trials found.